{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&_view=AnsweredQuestions&_properties=type.&_metadata=all&_sort=-answer.isMinisterialCorrection,,-type.", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "isPartOf" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "type" : "http://purl.org/linked-data/api/vocab#ListEndpoint"}
    , "items" : [{"_about" : "http://data.parliament.uk/resources/1000273", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1000273/answer", "answerText" : {"_value" : "<p>57 countries have adopted the London 2018 Declaration committing to action to protect endangered species around the globe, with more expected to sign. This important pledge of international action reflects the success of the Illegal Wildlife Trade Conference in London in October, which was attended by more than 70 countries and more than 400 organisations. The conference focused the minds of international governments on the issue and energized global cooperation to fight the illegal wildlife trade. We will continue to work with our international partners to make progress on commitments pledged at the event.<\/p><p>We do not have direct information on the likely impact that action by the 57 countries who adopted the London <ins class=\"ministerial\">2018 <\/ins>Declaration will have on endangered species, but the growing number of signatories <ins class=\"ministerial\">signifies <\/ins>growing global ambition to <del class=\"ministerial\">funding<\/del> <ins class=\"ministerial\">tackling <\/ins>the illegal wildlife trade, which will increase the protection for <del class=\"ministerial\">endagered<\/del> <ins class=\"ministerial\">endangered <\/ins>species.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1405", "label" : {"_value" : "Biography information for Mark Field"}
        }
        , "answeringMemberConstituency" : {"_value" : "Cities of London and Westminster"}
        , "answeringMemberPrinted" : {"_value" : "Mark Field"}
        , "dateOfAnswer" : {"_value" : "2018-11-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1000273/answer/previousversion/84424", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1405", "label" : {"_value" : "Biography information for Mark Field"}
          }
          , "answeringMemberConstituency" : {"_value" : "Cities of London and Westminster"}
          , "answeringMemberPrinted" : {"_value" : "Mark Field"}
        }
        , "questionFirstAnswered" : [{"_value" : "2018-11-12T16:27:27.317Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-11-23T15:08:04.16Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "16"}
      , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"}
      , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"}
      , "date" : {"_value" : "2018-11-02", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Wildlife: Smuggling"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, how many nations have now signed up to the London Declaration from the International Wildlife Trade Conference 2018; and what assessment he has made of the implications of that number for the endangered species trade.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hendon"}
      , "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "187342"}
    , {"_about" : "http://data.parliament.uk/resources/100080", "AnsweringBody" : [{"_value" : "Attorney General"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100080/answer", "answerText" : {"_value" : "<p>The Treasury Solicitor\u2019s Department holds records relating only to those cases in which it has acted. The Treasury Solicitor represents most, but not all, government departments in litigation. For example, Her Majesty\u2019s Revenue and Customs normally conducts its own litigation. According to records held by the Treasury Solicitor, the number of judicial reviews involving government departments in which it has acted in each of the last four years is as follows:<\/p><p>2010 \u2013 8,566<\/p><p>2011 \u2013 9,603<\/p><p>2012 \u2013 10,274<\/p><p>2013 \u2013 16,449<\/p><p>Information relating to how many of those reviews were upheld in whole or in part in each year is not held centrally and could not be created without incurring disproportionate cost.<\/p><p><del class=\"ministerial\">The Administrative Court Office does not collate the information requested centrally and determining the number of reviews and how many such reviews were upheld in whole or in part would incur a disproportionate cost.<\/del><\/p><p><ins class=\"ministerial\">The information requested in respect of the Administrative Court Office is published online at <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267408/additional-court-tables-2012.xls\" target=\"_blank\">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267408/additional-court-tables-2012.xls<\/a> . The 2013 data is not currently available.<\/ins><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4106", "label" : {"_value" : "Biography information for Sir Robert Buckland"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Swindon"}
        , "answeringMemberPrinted" : {"_value" : "Mr Robert Buckland"}
        , "dateOfAnswer" : {"_value" : "2014-10-28", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100080/answer/previousversion/24759", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4106", "label" : {"_value" : "Biography information for Sir Robert Buckland"}
          }
          , "answeringMemberConstituency" : {"_value" : "South Swindon"}
          , "answeringMemberPrinted" : {"_value" : "Mr Robert Buckland"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-28T15:10:43.167Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-01-05T17:35:17.82Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "88"}
      , "answeringDeptShortName" : {"_value" : "Attorney General"}
      , "answeringDeptSortName" : {"_value" : "Attorney General"}
      , "date" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Judicial Review"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Attorney General, how many judicial reviews there were involving Government departments according to records held by the (a) Treasury Solicitor and (b) Administrative Court Office in each of the last four years; and how many such reviews were upheld in whole or in part in each such year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1516", "label" : {"_value" : "Biography information for Andy Slaughter"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hammersmith"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Andy Slaughter"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211271"}
    , {"_about" : "http://data.parliament.uk/resources/100157", "AnsweringBody" : [{"_value" : "Department for Energy and Climate Change"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100157/answer", "answerText" : {"_value" : "<p>The projected allocation from the levy control framework for feed in tariffs, the renewables obligation and projects agreed under the final investment decision-enabling process in financial years from 2015/16 to 2020/21 <del class=\"ministerial\">will be<\/del> <ins class=\"ministerial\">is expected to be<\/ins> published in an annex (\u2018DECC\u2019s Consumer Funded Policies \u2013 a report to Parliament\u2019) to the Annual Energy Statement.<\/p><p>Publication of the Annual Energy Statement is expected in Autumn 2014.<\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4070", "label" : {"_value" : "Biography information for Matt Hancock"}
        }
        , "answeringMemberConstituency" : {"_value" : "West Suffolk"}
        , "answeringMemberPrinted" : {"_value" : "Matthew Hancock"}
        , "dateOfAnswer" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100157/answer/previousversion/24144", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4070", "label" : {"_value" : "Biography information for Matt Hancock"}
          }
          , "answeringMemberConstituency" : {"_value" : "West Suffolk"}
          , "answeringMemberPrinted" : {"_value" : "Matthew Hancock"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-24T13:35:38.18Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-28T16:37:54.0238756Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "63"}
      , "answeringDeptShortName" : {"_value" : "Energy and Climate Change"}
      , "answeringDeptSortName" : {"_value" : "Energy and Climate Change"}
      , "date" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Energy: Prices"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Energy and Climate Change, what estimate he has made of the likely total allocation from the levy control framework for (a) feed in tariffs, (b) renewables obligations and (c) projects agreed under the final investment decision-enabling process in each year from 2015 to 2021.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4047", "label" : {"_value" : "Biography information for Tom Greatrex"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rutherglen and Hamilton West"}
      , "tablingMemberPrinted" : [{"_value" : "Tom Greatrex"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211400"}
    , {"_about" : "http://data.parliament.uk/resources/100186", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100186/answer", "answerText" : {"_value" : "<p>Missed or inadequate hydrocortisone administration is not currently included in the list of \u2018never events\u2019.<\/p><p> <\/p><p> <\/p><p> <\/p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-28", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100186/answer/previousversion/24770", "answeringMember" : "http://data.parliament.uk/members/3918", "answeringMemberConstituency" : {"_value" : "Battersea"}
          , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-28T15:28:25.797Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-28T16:30:53.2329022Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Patients: Safety"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/95", "label" : {"_value" : "Biography information for Mr Andrew Smith"}
      }
      , "tablingMemberConstituency" : {"_value" : "Oxford East"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Andrew Smith"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211233"}
    , {"_about" : "http://data.parliament.uk/resources/1002115", "AnsweringBody" : [{"_value" : "Ministry of Justice"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1002115/answer", "answerText" : {"_value" : "<p>The information requested is provided in the attached table. As per the answer to PQ 184996, please note that offenders may appear both within the caseload figures of court orders (including community orders and suspended sentence orders), and post-release supervision.<\/p><p> <\/p><p>The National Probation Service and Community Rehabilitation Companies work closely with other agencies to support offenders in the community. When an offender being supervised by Probation dies, the Probation provider must examine the circumstances of the death and identify areas to improve practice. While we work extremely closely with each offender before and after release to help them find the support they need, we do not have sole responsibility for caring for these offenders. We are clear, however, that they should receive the same level of care as other members of the public.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4137", "label" : {"_value" : "Biography information for Rory Stewart"}
        }
        , "answeringMemberConstituency" : {"_value" : "Penrith and The Border"}
        , "answeringMemberPrinted" : {"_value" : "Rory Stewart"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1002115/answer/attachment/1", "fileName" : {"_value" : "PQ 188194 - table.xlsx"}
          , "title" : "PQ188194 - Table"}
        , "dateOfAnswer" : {"_value" : "2018-11-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1002115/answer/previousversion/84891", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4137", "label" : {"_value" : "Biography information for Rory Stewart"}
          }
          , "answeringMemberConstituency" : {"_value" : "Penrith and The Border"}
          , "answeringMemberPrinted" : {"_value" : "Rory Stewart"}
        }
        , "questionFirstAnswered" : [{"_value" : "2018-11-14T17:01:11.393Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-11-21T11:59:57.143Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "54"}
      , "answeringDeptShortName" : {"_value" : "Justice"}
      , "answeringDeptSortName" : {"_value" : "Justice"}
      , "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Probation: Death"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Justice, pursuant to the Answer of 1 November 2018 to Question 184996 on Probation: Death, if he will provide that information for each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4493", "label" : {"_value" : "Biography information for Richard Burgon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leeds East"}
      , "tablingMemberPrinted" : [{"_value" : "Richard Burgon"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "188194"}
    , {"_about" : "http://data.parliament.uk/resources/1003620", "AnsweringBody" : [{"_value" : "Department for Transport"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1003620/answer", "answerText" : {"_value" : "<p>The Airports National Policy Statement (NPS) was designated on 26 <del class=\"ministerial\">July<\/del> <ins class=\"ministerial\">June<\/ins> 2018, paving the way for a development consent application. As part of the development of the Airports NPS, an Appraisal of Sustainability was undertaken which included analysis of surface impacts for all three options shortlisted by the Airports Commission.<\/p><p> <\/p><p>As part of the surface access requirements in the Airports NPS, the Government has specified that any applicant for development consent must submit a surface access strategy as part of their application.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3991", "label" : {"_value" : "Biography information for Jesse Norman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Hereford and South Herefordshire"}
        , "answeringMemberPrinted" : {"_value" : "Jesse Norman"}
        , "dateOfAnswer" : {"_value" : "2018-11-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1003620/answer/previousversion/85388", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3991", "label" : {"_value" : "Biography information for Jesse Norman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Hereford and South Herefordshire"}
          , "answeringMemberPrinted" : {"_value" : "Jesse Norman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2018-11-19T10:54:12.873Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-11-26T16:27:02.787Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "27"}
      , "answeringDeptShortName" : {"_value" : "Transport"}
      , "answeringDeptSortName" : {"_value" : "Transport"}
      , "date" : {"_value" : "2018-11-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Heathrow Airport: Road Traffic"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Transport, what assessment he has made of the potential effect of the expansion of Heathrow Airport on local road networks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1516", "label" : {"_value" : "Biography information for Andy Slaughter"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hammersmith"}
      , "tablingMemberPrinted" : [{"_value" : "Andy Slaughter"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "189623"}
    , {"_about" : "http://data.parliament.uk/resources/1006207", "AnsweringBody" : [{"_value" : "Cabinet Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1006207/answer", "answerText" : {"_value" : "<p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1609", "label" : {"_value" : "Biography information for Chloe Smith"}
        }
        , "answeringMemberConstituency" : {"_value" : "Norwich North"}
        , "answeringMemberPrinted" : {"_value" : "Chloe Smith"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1006207/answer/attachment/1", "fileName" : {"_value" : "PQ190816 (1).pdf"}
          , "title" : "UKSA Response"}
        , "dateOfAnswer" : {"_value" : "2018-11-21", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1006207/answer/previousversion/86293", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1609", "label" : {"_value" : "Biography information for Chloe Smith"}
          }
          , "answeringMemberConstituency" : {"_value" : "Norwich North"}
          , "answeringMemberPrinted" : {"_value" : "Chloe Smith"}
        }
        , "questionFirstAnswered" : [{"_value" : "2018-11-21T12:50:19.553Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-12-12T17:10:40.713Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "53"}
      , "answeringDeptShortName" : {"_value" : "Cabinet Office"}
      , "answeringDeptSortName" : {"_value" : "Cabinet Office"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Electronic Cigarettes"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Minister for the Cabinet Office, what the contribution of the vaping industry is to the economy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1447", "label" : {"_value" : "Biography information for Andrew Rosindell"}
      }
      , "tablingMemberConstituency" : {"_value" : "Romford"}
      , "tablingMemberPrinted" : [{"_value" : "Andrew Rosindell"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "190816"}
    , {"_about" : "http://data.parliament.uk/resources/100721", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100721/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100721/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Osteoporosis"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211732"}
    , {"_about" : "http://data.parliament.uk/resources/100723", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100723/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100723/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Motor Neurone Disease: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211734"}
    , {"_about" : "http://data.parliament.uk/resources/100728", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100728/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100728/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Motor Neurone Disease"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "211730"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&houseId=1&_view=AnsweredQuestions&_properties=type.&_sort=-answer.isMinisterialCorrection,,-type.", "page" : 0, "startIndex" : 1, "totalResults" : 444335, "type" : "http://purl.org/linked-data/api/vocab#Page"}
}